Moberly SP, Mather KJ, Berwick ZC, Owen MK, Goodwill AG, Casalini ED, Hutchins GD, Green MA, Ng Y, Considine RV, Perry KM, Chisholm RL, Tune JD: Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus
Introduction In the realm of weight loss, a promising player has emerged - GLP-1, short for glucagon-like peptide-1
Some products require refrigeration
In June 2025, Amgen reported robust results from its Phase2 clinical study of MariTide, a monthly injectable bispecific GLP-1/GIP receptor agonist
People with pre-existing thyroid conditions should be particularly cautious with iodine-rich supplements and only use them under medical supervision
Our innovative liquid fat burner helps you increase thermogenesis and boost calorie burning to help you achieve your weight loss goals.